{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:26Z","timestamp":1786650026380,"version":"build-2736575974"},"reference-count":109,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Chronic neuropathic pain due to injury or dysfunction of the nervous system, which intensifies as it continues, affects millions of people and remains a formidable treatment challenge in spite of a growing range of medication choices. This neuropathy can range from mild to extreme in pain levels. In spite of several experimental and animal studies on neuropathic pain, its pathophysiologic mechanisms have not been completely understood. The pharmacotherapy for neuropathic pain has had a limited success with little or no response to commonly-used pain-reducing drugs, such as nonsteroidal anti-inflammatory drugs and opiates. Recent research efforts into pathophysiological mechanisms have revealed new treatment targets, new classification schemes have opened up novel options for individualized treatment strategies, and the implementation of several international guidelines should help to improve care of patients. This review brie\ufb02y summarizes the theoretical development and experimental evidence of recent and novel emerging drug target the glutaminergic system, for neuropathic pain treatment. Sustained efforts on this novel drug target can expedite the development of lead compounds to reach the clinical stage, which will broaden our pharmacotherapeutic armaments against various debilitating, painful conditions.<\/jats:p>","DOI":"10.4103\/ant.ant-d-25-00046","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:00:14Z","timestamp":1767189614000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Glutaminergic Modulators as Potential Therapeutic Modalities for Neuropathic Pain"],"prefix":"10.4103","volume":"35","author":[{"given":"Butchi Raju","family":"Akondi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology, Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Reddy","family":"Challa","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, Peoria, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Bandarupalli","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vara Prasad","family":"Saka","sequence":"additional","affiliation":[{"name":"Dr. Anjali Chatterji Regional Research Institute for Homoeopathy, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mallamma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G. Nagar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: Redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: A maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","article-title":"Allodynia and hyperalgesia in neuropathic pain: Clinical manifestations and mechanisms","volume":"13","author":"Jensen","year":"2014","journal-title":"Lancet Neurol"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11916-017-0629-5","article-title":"Neuropathic pain: Central versus peripheral mechanisms","volume":"21","author":"Meacham","year":"2017","journal-title":"Curr Pain Headache Rep"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2011.05.005","article-title":"Mechanisms of neuropathic pain","volume":"22","author":"Nickel","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ptsp.2005.10.002","article-title":"Management of peripheral neuropathic pain: Integrating neurobiology, neurodynamics, and clinical evidence","volume":"7","author":"Nee","year":"2006","journal-title":"Phys Ther Sport"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1213\/01.ane.0000275190.42912.37","article-title":"Pathophysiology of peripheral neuropathic pain: Immune cells and molecules","volume":"105","author":"Thacker","year":"2007","journal-title":"Anesth Analg"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(25)00068-7","article-title":"Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: A systematic review and meta-analysis","volume":"24","author":"Soliman","year":"2025","journal-title":"Lancet Neurol"},{"key":"R10-20260420","doi-asserted-by":"crossref","DOI":"10.1002\/9780470015902.a0000139.pub3","article-title":"Glutamate as a Neurotransmitter","author":"Mennerick","year":"2012"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cne.903430307","article-title":"Ionotropic glutamate-receptor gene expression in hypothalamus: Localization of AMPA, kainate, and NMDA receptor RNA with in situ hybridization","volume":"343","author":"van den Pol","year":"1994","journal-title":"J Comp Neurol"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0959-4388(03)00067-9","article-title":"Structure of the metabotropic glutamate receptor","volume":"13","author":"Jingami","year":"2003","journal-title":"Curr Opin Neurobiol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.08.070","article-title":"High extracellular glutamate modulates expression of glutamate transporters and glutamine synthetase in cultured astrocytes","volume":"1297","author":"Lehmann","year":"2009","journal-title":"Brain Res"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuint.2005.10.015","article-title":"Glutaminase: A multifaceted protein not only involved in generating glutamate","volume":"48","author":"M\u00e1rquez","year":"2006","journal-title":"Neurochem Int"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5607\/en.2014.23.1.28","article-title":"Disturbance of the glutamatergic system in mood disorders","volume":"23","author":"Jun","year":"2014","journal-title":"Exp Neurobiol"},{"key":"R17-20260420","first-page":"4","article-title":"Glutamatergic theories of schizophrenia","volume":"47","author":"Javitt","year":"2010","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cub.2011.08.020","article-title":"Hedgehog signaling regulates nociceptive sensitization","volume":"21","author":"Babcock","year":"2011","journal-title":"Curr Biol"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar3305","article-title":"Update on peripheral mechanisms of pain: Beyond prostaglandins and cytokines","volume":"13","author":"Schaible","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: A generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J Pain"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-0082(99)00051-9","article-title":"Wind-up of spinal cord neurones and pain sensation: Much ado about something?","volume":"61","author":"Herrero","year":"2000","journal-title":"Prog Neurobiol"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","article-title":"Metabotropic glutamate receptors","volume":"326","author":"Ferraguti","year":"2006","journal-title":"Cell Tissue Res"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2006.08.008","article-title":"Metabotropic glutamate receptors: Intracellular signaling pathways","volume":"7","author":"Gerber","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: Physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1213\/01.ANE.0000081061.12235.55","article-title":"The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review","volume":"97","author":"Petrenko","year":"2003","journal-title":"Anesth Analg"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1523\/JNEUROSCI.23-12-05031.2003","article-title":"A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain","volume":"23","author":"South","year":"2003","journal-title":"J Neurosci"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1744-8069-4-44","article-title":"Functional identification of NR2 subunits contributing to NMDA receptors on substance P receptor-expressing dorsal horn neurons","volume":"4","author":"Tong","year":"2008","journal-title":"Mol Pain"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00000542-200203000-00018","article-title":"Pharmacology of spinal glutamatergic receptors in post-thermal injury-evoked tactile allodynia and thermal hyperalgesia","volume":"96","author":"Nozaki-Taguchi","year":"2002","journal-title":"Anesthesiology"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cveq.2010.07.009","article-title":"NMDA receptor antagonists and pain: Ketamine","volume":"26","author":"Muir","year":"2010","journal-title":"Vet Clin North Am Equine Pract"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8069-6-5","article-title":"Regulation of AMPA receptors in spinal nociception","volume":"6","author":"Wang","year":"2010","journal-title":"Mol Pain"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1523\/JNEUROSCI.12-09-03665.1992","article-title":"The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury","volume":"12","author":"Coderre","year":"1992","journal-title":"J Neurosci"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/138945008783431772","article-title":"Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy","volume":"9","author":"Anjaneyulu","year":"2008","journal-title":"Curr Drug Targets"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1523\/JNEUROSCI.23-22-08013.2003","article-title":"Distribution of kainate receptor subunits at hippocampal mossy fiber synapses","volume":"23","author":"Darstein","year":"2003","journal-title":"J Neurosci"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0896-6273(00)00126-4","article-title":"Subunit composition of kainate receptors in hippocampal interneurons","volume":"28","author":"Mulle","year":"2000","journal-title":"Neuron"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0896-6273(01)00221-5","article-title":"Presynaptic kainate receptors that enhance the release of GABA on CA1 hippocampal interneurons","volume":"29","author":"Cossart","year":"2001","journal-title":"Neuron"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-8069-2-29","article-title":"Presynaptic regulation of the inhibitory transmission by GluR5-containing kainate receptors in spinal substantia gelatinosa","volume":"2","author":"Xu","year":"2006","journal-title":"Mol Pain"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11302-010-9182-y","article-title":"Emerging structures and ligands for P2X (3) and P2X (4) receptors-towards novel treatments of neuropathic pain","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Purinergic Signal"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jpain.2009.08.006","article-title":"Activation of NMDA receptors in the brainstem, rostral ventromedial medulla, and nucleus reticularis gigantocellularis mediates mechanical hyperalgesia produced by repeated intramuscular injections of acidic saline in rats","volume":"11","author":"Da Silva","year":"2010","journal-title":"J Pain"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2013.09.045","article-title":"Kainate receptors in health and disease","volume":"80","author":"Lerma","year":"2013","journal-title":"Neuron"},{"key":"R41-20260420","first-page":"1325","article-title":"AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus","volume":"5","author":"Eastwood","year":"1994","journal-title":"Neuroreport"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: Prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"Biochem J"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1113\/jphysiol.2010.191080","article-title":"AMPA receptor activation controls type I metabotropic glutamate receptor signalling via a tyrosine kinase at parallel fibre-Purkinje cell synapses","volume":"588","author":"Auger","year":"2010","journal-title":"J Physiol"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/jpet.113.211532","article-title":"A real-time method for measuring cAMP production modulated by G\u03b1i\/o-coupled metabotropic glutamate receptors","volume":"349","author":"DiRaddo","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1097\/00001756-199708180-00012","article-title":"Metabotropic glutamate receptor mRNA expression in rat spinal cord","volume":"8","author":"Valerio","year":"1997","journal-title":"Neuroreport"},{"key":"R46-20260420","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"e00001","DOI":"10.1042\/AN20090006","article-title":"Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway","volume":"1","author":"Bagayogo","year":"2009","journal-title":"ASN Neuro"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/360471a0","article-title":"The glial cell glutamate uptake carrier countertransports pH-changing anions","volume":"360","author":"Bouvier","year":"1992","journal-title":"Nature"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1471-4159.1997.69010076.x","article-title":"Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: Involvement of the glutathione system","volume":"69","author":"Hou","year":"1997","journal-title":"J Neurochem"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/cvr\/cvx024","article-title":"Cardiac mGluR1 metabotropic receptors in cardioprotection","volume":"113","author":"Vincent","year":"2017","journal-title":"Cardiovasc Res"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0026-895X(24)12169-4","article-title":"CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding","volume":"55","author":"Litschig","year":"1999","journal-title":"Mol Pharmacol"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.114.215137","article-title":"AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects","volume":"350","author":"Swedberg","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"R54-20260420","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-3565(24)34881-5","article-title":"SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5","volume":"290","author":"Varney","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1300417","article-title":"Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release","volume":"29","author":"Homayoun","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/13543776.2013.760544","article-title":"mGlu5 negative allosteric modulators: A patent review (2010-2012)","volume":"23","author":"Emmitte","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1042\/BST0320881","article-title":"Allosteric modulators of metabotropic glutamate receptors: Lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists","volume":"32","author":"Johnson","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1124\/mol.112.082891","article-title":"A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling","volume":"83","author":"Noetzel","year":"2013","journal-title":"Mol Pharmacol"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1152\/jn.1996.76.6.3798","article-title":"Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses","volume":"76","author":"Macek","year":"1996","journal-title":"J Neurophysiol"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","article-title":"Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain","volume":"139","author":"Osikowicz","year":"2008","journal-title":"Pain"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0028-3908(96)00121-9","article-title":"The novel metabotropic glutamate receptor agonist 2R,4R\u2013APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: Evidence for a synergistic interaction between group 1 and group 2 receptors","volume":"35","author":"Schoepp","year":"1996","journal-title":"Neuropharmacology"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pain.2007.08.020","article-title":"Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain","volume":"137","author":"Goudet","year":"2008","journal-title":"Pain"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cct.2014.06.004","article-title":"Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients","volume":"38","author":"Pickering","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"R64-20260420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1213\/00000539-199907000-00017","article-title":"Small-dose ketamine enhances morphine-induced analgesia after outpatient surgery","volume":"89","author":"Suzuki","year":"1999","journal-title":"Anesth Analg"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: Risks and benefits","volume":"77","author":"Niesters","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.0001-5172.2004.0325.x","article-title":"Analgesic effect of dextromethorphan in neuropathic pain","volume":"48","author":"Carlsson","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1212\/WNL.48.5.1212","article-title":"High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia","volume":"48","author":"Nelson","year":"1997","journal-title":"Neurology"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1245\/ASO.2003.08.007","article-title":"Dextromethorphan mitigates phantom pain in cancer amputees","volume":"10","author":"Ben Abraham","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1358\/dot.2004.40.8.850471","article-title":"Memantine hydrochloride: Pharmacological and clinical profile","volume":"40","author":"M\u00f6bius","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"R70-20260420","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s005400170025","article-title":"Clinical application of amantadine, an NMDA antagonist, for neuropathic pain","volume":"15","author":"Fukui","year":"2001","journal-title":"Journal of Anesthesia"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.STR.31.2.347","article-title":"Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist","volume":"31","author":"Davis","year":"2000","journal-title":"Stroke"},{"key":"R72-20260420","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(00)03325-4","article-title":"Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist","volume":"894","author":"Davis","year":"2001","journal-title":"Brain Res"},{"key":"R73-20260420","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(24)37988-1","article-title":"Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/jpet.103.050039","article-title":"Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain","volume":"306","author":"Villetti","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2013.10.019","article-title":"Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: Improved transdermal absorption and evaluation of efficacy and safety","volume":"52","author":"Naruse","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"R76-20260420","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coph.2005.11.001","article-title":"Glutamate-based therapeutic approaches: NR2B receptor antagonists","volume":"6","author":"Gogas","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"R77-20260420","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11011-016-9810-5","article-title":"Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice","volume":"31","author":"Poleszak","year":"2016","journal-title":"Metab Brain Dis"},{"key":"R78-20260420","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.neuron.2015.02.008","article-title":"Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects","volume":"85","author":"Yuan","year":"2015","journal-title":"Neuron"},{"key":"R79-20260420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pbb.2013.09.007","article-title":"Antinociception and prevention of hyperalgesia by intrathecal administration of Ro 25-6981, a highly selective antagonist of the 2B subunit of N-methyl-D-aspartate receptor","volume":"112","author":"Jiang","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"R80-20260420","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00029330-200704020-00006","article-title":"Evaluation of NR2B peptide as subunit vaccines against experimental neuropathic pain","volume":"120","author":"Wang","year":"2007","journal-title":"Chin Med J (Engl)"},{"key":"R82-20260420","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.neuropharm.2006.12.002","article-title":"Characterisation of the human NMDA receptor subunit NR3A glycine binding site","volume":"52","author":"Nilsson","year":"2007","journal-title":"Neuropharmacology"},{"key":"R83-20260420","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0223-5234(03)00113-2","article-title":"Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions","volume":"38","author":"Jansen","year":"2003","journal-title":"Eur J Med Chem"},{"key":"R84-20260420","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/00912709922008164","article-title":"First time in human for GV196771: Interspecies scaling applied on dose selection","volume":"39","author":"Iavarone","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"R85-20260420","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/156802606776894465","article-title":"Glycine\/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA\u20131021 and related compounds","volume":"6","author":"Cai","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"R86-20260420","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(94)90777-3","article-title":"The glycine B receptor partial agonist, (+)-HA966, enhances induction of antinociception by RP 67580 and CP-99,994","volume":"253","author":"Seguin","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"R87-20260420","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s002109900179","article-title":"Short-acting NMDA receptor antagonist MRZ 2\/576 produces prolonged suppression of morphine withdrawal in mice","volume":"361","author":"Belozertseva","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R88-20260420","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pain.2012.02.003","article-title":"Effect of NMDA NR2B antagonist on neuropathic pain in two spinal cord injury models","volume":"153","author":"Kim","year":"2012","journal-title":"Pain"},{"key":"R89-20260420","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1097\/00001756-199909290-00011","article-title":"MK-801, an NMDA receptor antagonist, in the rostroventromedial medulla attenuates development of neuropathic symptoms in the rat","volume":"10","author":"Wei","year":"1999","journal-title":"Neuroreport"},{"key":"R90-20260420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1527-3458.1998.tb00073.x","article-title":"CP-101,606: An NR2B-selective NMDA receptor antagonist","volume":"4","author":"Menniti","year":"1998","journal-title":"CNS Drug Rev"},{"key":"R91-20260420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0028-3908(95)00030-A","article-title":"Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor","volume":"34","author":"McCool","year":"1995","journal-title":"Neuropharmacology"},{"key":"R92-20260420","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.2000.0750174.x","article-title":"Changes in NMDA receptor subunit expression in response to contusive spinal cord injury","volume":"75","author":"Grossman","year":"2000","journal-title":"J Neurochem"},{"key":"R93-20260420","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2007.05.018","article-title":"Regulation of NMDA receptors by phosphorylation","volume":"53","author":"Chen","year":"2007","journal-title":"Neuropharmacology"},{"key":"R94-20260420","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1527-3458.2002.tb00232.x","article-title":"YM872: A selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist","volume":"8","author":"Takahashi","year":"2002","journal-title":"CNS Drug Rev"},{"key":"R95-20260420","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0028-3908(01)00135-6","article-title":"CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA\/kainate receptor-independent mechanism","volume":"41","author":"Brickley","year":"2001","journal-title":"Neuropharmacology"},{"key":"R96-20260420","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2004.04.007","article-title":"Behavioural effects of the novel AMPA\/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain","volume":"47","author":"Blackburn-Munro","year":"2004","journal-title":"Neuropharmacology"},{"key":"R97-20260420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(99)02437-3","article-title":"SYM-2081 a kainate receptor antagonist reduces allodynia and hyperalgesia in a freeze injury model of neuropathic pain","volume":"858","author":"Ta","year":"2000","journal-title":"Brain Res"},{"key":"R98-20260420","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(03)02525-3","article-title":"SYM 2081, an agonist that desensitizes kainate receptors, attenuates capsaicin and inflammatory hyperalgesia","volume":"973","author":"Turner","year":"2003","journal-title":"Brain Res"},{"key":"R99-20260420","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jpain.2006.03.010","article-title":"The effect of the AMPA\/kainate receptor antagonist LY293558 in a rat model of postoperative pain","volume":"7","author":"Lee","year":"2006","journal-title":"J Pain"},{"key":"R100-20260420","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-2982.2004.00723.x","article-title":"LY293558, a novel AMPA\/GluR5 antagonist, is efficacious and well-tolerated in acute migraine","volume":"24","author":"Sang","year":"2004","journal-title":"Cephalalgia"},{"key":"R101-20260420","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2005.01.088","article-title":"Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model","volume":"1041","author":"Binns","year":"2005","journal-title":"Brain Res"},{"key":"R102-20260420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pain.2006.12.020","article-title":"Altered spinal arachidonic acid turnover after peripheral nerve injury regulates regional glutamate concentration and neuropathic pain behaviors in rats","volume":"131","author":"Sung","year":"2007","journal-title":"Pain"},{"key":"R103-20260420","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"R104-20260420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6446(00)01486-0","article-title":"NAALADase inhibitors: A novel approach to glutamate regulation","volume":"5","author":"Whelan","year":"2000","journal-title":"Drug Discov Today"},{"key":"R105-20260420","article-title":"Measurement of glutamate carboxypeptidase II (NAALADase) enzyme activity by the hydrolysis of [\u00b3H]-N-acetylaspartylglutamate (NAAG)","author":"Tiffany","year":"2002","journal-title":"Curr Protoc Pharmacol"},{"key":"R106-20260420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpba.2013.08.028","article-title":"Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)","volume":"88","author":"Rais","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"R107-20260420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(00)00519-7","article-title":"Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons","volume":"402","author":"Tortella","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R108-20260420","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.12.008","article-title":"Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats","volume":"508","author":"Long","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R109-20260420","doi-asserted-by":"crossref","first-page":"e102936","DOI":"10.1371\/journal.pone.0102936","article-title":"Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats","volume":"9","author":"Potter","year":"2014","journal-title":"PLoS One"},{"key":"R110-20260420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1460-9568.2004.03504.x","article-title":"Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ\u201317 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Eur J Neurosci"},{"key":"R111-20260420","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/jm020515w","article-title":"Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: Discovery of an orally active GCP II inhibitor","volume":"46","author":"Majer","year":"2003","journal-title":"J Med Chem"}],"container-title":["Acta Neurologica Taiwanica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ant.ANT-D-25-00046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:01:12Z","timestamp":1786647672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ant.ANT-D-25-00046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ant.ant-d-25-00046","relation":{},"ISSN":["1028-768X","3050-9173"],"issn-type":[{"value":"1028-768X","type":"print"},{"value":"3050-9173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"2025-03-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}